ArticleBiotechnology reports (Amsterdam, Netherlands)2026

Production and characterization of rNGFSP: a recombinant fusion immunogen eliciting dual anti-NGF and anti-Substance P therapeutic antibodies for Degenerative Joint Disease.

Valentina Varela et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.